Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue European Journal of Vascular and Endovascular Surgery Année : 2021

Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials

Stefanie von Felten
  • Fonction : Auteur
Andrea Wiencierz
  • Fonction : Auteur
Olav Jansen
  • Fonction : Auteur
George Howard
  • Fonction : Auteur
Jeroen Hendrikse
  • Fonction : Auteur
Alison Halliday
  • Fonction : Auteur
Gustav Fraedrich
  • Fonction : Auteur
Hans-Henning Eckstein
  • Fonction : Auteur
Richard Bulbulia
  • Fonction : Auteur
Jean-Pierre Becquemin
  • Fonction : Auteur
Ale Algra
  • Fonction : Auteur
Peter Rothwell
  • Fonction : Auteur
Peter Ringleb
  • Fonction : Auteur
Jean-Louis Mas
  • Fonction : Auteur
Martin Brown
  • Fonction : Auteur
Thomas Brott
  • Fonction : Auteur

Résumé

Objective: Current guidelines recommending rapid revascularisation of symptomatic carotid stenosis are largely based on data from clinical trials performed at a time when best medical therapy was potentially less effective than today. The risk of stroke and its predictors among patients with symptomatic carotid stenosis awaiting revascularisation in recent randomised controlled trials (RCTs) and in medical arms of earlier RCTs was assessed. Methods: The pooled data of individual patients with symptomatic carotid stenosis randomised to stenting (CAS) or endarterectomy (CEA) in four recent RCTs, and of patients randomised to medical therapy in three earlier RCTs comparing CEA vs. medical therapy, were compared. The primary outcome event was any stroke occurring between randomisation and treatment by CAS or CEA, or within 120 days after randomisation. Results: A total of 4 754 patients from recent trials and 1 227 from earlier trials were included. In recent trials, patients were randomised a median of 18 (IQR 7, 50) days after the qualifying event (QE). Twenty-three suffered a stroke while waiting for revascularisation (cumulative 120 day risk 1.97%, 95% confidence interval [CI] 0.75 - 3.17). Shorter time from QE until randomisation increased stroke risk after randomisation (χ2 = 6.58, p = .011). Sixty-one patients had a stroke within 120 days of randomisation in the medical arms of earlier trials (cumulative risk 5%, 95% CI 3.8 - 6.2). Stroke risk was lower in recent than earlier trials when adjusted for time between QE and randomisation, age, severity of QE, and degree of carotid stenosis (HR 0.47, 95% CI 0.25 - 0.88, p = .019). Conclusion: Patients with symptomatic carotid stenosis enrolled in recent large RCTs had a lower risk of stroke after randomisation than historical controls. The added benefit of carotid revascularisation to modern medical care needs to be revisited in future studies. Until then, adhering to current recommendations for early revascularisation of patients with symptomatic carotid stenosis considered to require invasive treatment is advisable.

Dates et versions

hal-03258509 , version 1 (11-06-2021)

Identifiants

Citer

Urs Fisch, Stefanie von Felten, Andrea Wiencierz, Olav Jansen, George Howard, et al.. Risk of Stroke before Revascularisation in Patients with Symptomatic Carotid Stenosis: A Pooled Analysis of Randomised Controlled Trials. European Journal of Vascular and Endovascular Surgery, 2021, ⟨10.1016/j.ejvs.2021.02.024⟩. ⟨hal-03258509⟩

Collections

UP-SANTE
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More